TGF-β secreted by tumor cells favors the immunosuppression in the tumor microenvironment and also modulates the neutrophil phenotype within the tumor region, promoting their polarization toward an anti-inflammatory N2 profile, which is generally protumor [74]. The gene discussed is TGFB1; the disease is neoplasm.